NWD says it has not received proposal from Cheng family on capital injection



New World Development (NWD) shares dropped on Tuesday after the property developer said it has not received a proposal from its controlling shareholder, the billionaire Cheng family, on a capital injection.

“Save that the company is in discussions with respect to a loan facility led by Deutsche Bank as part of the company’s ordinary course financing activities, the company has not received any funding proposal as alleged in the rumours,” NWD said on Monday night.

NWD’s shares fell 2.7 per cent to HK$6.88 as of 11.27am after closing 6.8 per cent higher on Monday.

On Monday, Bloomberg News reported that the Cheng family was considering injecting capital into the Hong Kong developer as early as the end of 2025, citing people familiar with the matter.

The report said the family of Hong Kong tycoon Henry Cheng Kar-shun was willing to contribute about HK$10 billion (US$1.3 billion) and was seeking a partner that could provide a roughly similar amount for an equity stake. The plan under discussion would establish a joint venture to provide liquidity to NWD, the report said, adding that talks were ongoing and details about the deal’s size and structure could change.

Blackstone and CapitaLand Group were among the firms engaged in the discussions, the report said. The two companies had also been in talks with NWD to buy some of its assets, it added.

  • Related Posts

    Lean harder into Hong Kong-mainland China market ties, ‘two sessions’ delegates urge

    Hong Kong can reinforce its role as an international financial centre by deepening integration with mainland capital markets and expanding cross-border investment channels, financial industry leaders said on Thursday during…

    Continue reading
    Insilico Medicine advances Middle East push with UAE AI drug discovery deal

    Hong Kong-listed Insilico Medicine has signed a cooperation agreement with the United Arab Emirates’ drug regulator to advance the use of its artificial intelligence tools in drug discovery across the…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *